These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
229 related articles for article (PubMed ID: 8190328)
1. Immunosuppressive therapy with cyclophosphamide and prednisolone in severe idiopathic membranous nephropathy. Kibriya MG; Tishkov I; Nikolov D Nephrol Dial Transplant; 1994; 9(2):138-43. PubMed ID: 8190328 [TBL] [Abstract][Full Text] [Related]
2. Long-term outcomes of idiopathic membranous nephropathy in Japanese patients treated with low-dose cyclophosphamide and prednisolone. Eriguchi M; Oka H; Mizobuchi T; Kamimura T; Sugawara K; Harada A Nephrol Dial Transplant; 2009 Oct; 24(10):3082-8. PubMed ID: 19465558 [TBL] [Abstract][Full Text] [Related]
3. Prednisolone and azathioprine in membranous nephropathy: a 10-year follow-up study. Goumenos DS; Ahuja M; Davlouros P; El Nahas AM; Brown CB Clin Nephrol; 2006 May; 65(5):317-23. PubMed ID: 16724651 [TBL] [Abstract][Full Text] [Related]
4. Short- and long-term efficacy of oral cyclophosphamide and steroids in patients with membranous nephropathy and renal insufficiency. Study Group. Branten AJ; Wetzels JF Clin Nephrol; 2001 Jul; 56(1):1-9. PubMed ID: 11499653 [TBL] [Abstract][Full Text] [Related]
5. Early versus late start of immunosuppressive therapy in idiopathic membranous nephropathy: a randomized controlled trial. Hofstra JM; Branten AJ; Wirtz JJ; Noordzij TC; du Buf-Vereijken PW; Wetzels JF Nephrol Dial Transplant; 2010 Jan; 25(1):129-36. PubMed ID: 19666912 [TBL] [Abstract][Full Text] [Related]
6. Beta-2-microglobulin is superior to N-acetyl-beta-glucosaminidase in predicting prognosis in idiopathic membranous nephropathy. Hofstra JM; Deegens JK; Willems HL; Wetzels JF Nephrol Dial Transplant; 2008 Aug; 23(8):2546-51. PubMed ID: 18308774 [TBL] [Abstract][Full Text] [Related]
7. Introduction of a cyclophosphamide-based treatment strategy and the risk of ESRD in patients with idiopathic membranous nephropathy: a nationwide survey in the Netherlands. Hofstra JM; Wetzels JF Nephrol Dial Transplant; 2008 Nov; 23(11):3534-8. PubMed ID: 18559961 [TBL] [Abstract][Full Text] [Related]
8. Early initiation of tacrolimus or cyclophosphamide therapy for idiopathic membranous nephropathy with severe proteinuria. Li X; Lv R; He Q; Li H; Du X; Lin W; Li Q; He X; Wang S; Chen J J Nephrol; 2008; 21(4):584-91. PubMed ID: 18651550 [TBL] [Abstract][Full Text] [Related]
9. Cytotoxic therapy for membranous nephropathy and renal insufficiency: improved renal survival but high relapse rate. du Buf-Vereijken PW; Branten AJ; Wetzels JF; Nephrol Dial Transplant; 2004 May; 19(5):1142-8. PubMed ID: 14993502 [TBL] [Abstract][Full Text] [Related]
10. Efficacy of a second course of immunosuppressive therapy in patients with membranous nephropathy and persistent or relapsing disease activity. du Buf-Vereijken PW; Wetzels JF Nephrol Dial Transplant; 2004 Aug; 19(8):2036-43. PubMed ID: 15187191 [TBL] [Abstract][Full Text] [Related]
11. A randomized, controlled trial of steroids and cyclophosphamide in adults with nephrotic syndrome caused by idiopathic membranous nephropathy. Jha V; Ganguli A; Saha TK; Kohli HS; Sud K; Gupta KL; Joshi K; Sakhuja V J Am Soc Nephrol; 2007 Jun; 18(6):1899-904. PubMed ID: 17494881 [TBL] [Abstract][Full Text] [Related]
12. The effect of treatment with prednisolone or cyclophosphamide-warfarin-dipyridamole combination on the outcome of patients with membranous nephropathy. Shearman JD; Yin ZG; Aarons I; Smith PS; Woodroffe AJ; Clarkson AR Clin Nephrol; 1988 Dec; 30(6):320-9. PubMed ID: 3243041 [TBL] [Abstract][Full Text] [Related]
13. Focal segmental glomerulosclerosis is not a sufficient predictor of renal outcome in patients with membranous nephropathy. Heeringa SF; Branten AJ; Deegens JK; Steenbergen E; Wetzels JF Nephrol Dial Transplant; 2007 Aug; 22(8):2201-7. PubMed ID: 17442739 [TBL] [Abstract][Full Text] [Related]
14. Effective treatment administration of cyclophosphamide in membranous nephropathy. Dede F; Ayili D; Sahiner S J Nephrol; 2008; 21(4):560-5. PubMed ID: 18651546 [TBL] [Abstract][Full Text] [Related]
15. Prognosis and management of membraneous nephropathy. Pahari DK; Das S; Dutta BN; Banerjee D J Assoc Physicians India; 1993 Jun; 41(6):350-1. PubMed ID: 8005970 [TBL] [Abstract][Full Text] [Related]
16. Clinical and morphological prognostic factors in membranous nephropathy: significance of focal segmental glomerulosclerosis. Dumoulin A; Hill GS; Montseny JJ; Meyrier A Am J Kidney Dis; 2003 Jan; 41(1):38-48. PubMed ID: 12500220 [TBL] [Abstract][Full Text] [Related]
17. Low-dose angiotensin-converting-enzyme inhibitor captopril to reduce proteinuria in adult idiopathic membranous nephropathy: a prospective study of long-term treatment. Rostoker G; Ben Maadi A; Remy P; Lang P; Lagrue G; Weil B Nephrol Dial Transplant; 1995; 10(1):25-9. PubMed ID: 7724024 [TBL] [Abstract][Full Text] [Related]
18. Treatment-related changes in urinary excretion of high and low molecular weight proteins in patients with idiopathic membranous nephropathy and renal insufficiency. du Buf-Vereijken PW; Wetzels JF Nephrol Dial Transplant; 2006 Feb; 21(2):389-96. PubMed ID: 16234291 [TBL] [Abstract][Full Text] [Related]